Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Odevo in connection with the acquisition of OBOS’ 40% minority stake in SBC and OBOS subsequent investment in Odevo
Mandate

Vinge advises Odevo in connection with the acquisition of OBOS’ 40% minority stake in SBC and OBOS subsequent investment in Odevo

April 13, 2022 M&A

Vinge advises Odevo in connection with the acquisition of OBOS minority stake of approx. 40 percent in SBC Intressenter HoldCo AB ("SBC") and OBOS’ subsequent investment in Odevo.

OBOS has been a minority investor in SBC since 2019. Through the divestment of its shares in SBC to Odevo, SBC becomes wholly owned by Odevo. Odevo was launched in February and is a new international player that challenges the traditional industry for property and housing management. The foundation for the group was created in 2019 through the formation of Nabo and the acquisition of SBC, and since then the group has grown into a leading international player. The companies within Odevo offer services to residents and property owners supported by Odevo’s own developed platform. The Odevo Group consists of a total of approximately 1,300 employees and has a turnover of just over SEK 1.5 billion.

Vinge’s team consisted of among others Jonas Bergstöm, Joacim Rydergård and Clara Sohlberg.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025